“Development And Toxicological Evolution Of Pegylated Chitosan Nanoparticle For The Simultaneous Delivery Of Silymarin And Dehydroemetine For The Enhance Hepatic Targeting” (2023) Journal of Pharmaceutical Negative Results, pp. 4732–4739. doi:10.47750/pnr.2022.13.S08.617.